Consumer preferences for drug information after direct-to-consumer advertising

被引:0
|
作者
Doucette, WR
Schommer, JC
机构
[1] Univ Iowa, Div Clin & Adm Pharm, Iowa City, IA 52242 USA
[2] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA
来源
DRUG INFORMATION JOURNAL | 1998年 / 32卷 / 04期
关键词
direct-to-consumer advertising; information search; prescription drug information;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Despite the growth of direct-to-consumer (DTC) advertising of prescription drugs, little is known about consumers' preferences for drug information after exposure to such an ad. The objective of this research was to investigate the effects of patient age, self-perceived medication knowledge, and the context of exposure to direct-to-consumer prescription drug advertising on consumers' preferences for information about benefits, risks, and costs of prescription drugs. A mail survey sent to a random sample of 360 consumers was used to collect preferences for three types of drug information (benefit, risk and cost of the drug) from six information sources (a physician, a pharmacist, a nurse, a family member or friend, a medical reference book, and the manufacturer of the product). The effects of age, medication knowledge, and context on consumer preferences were assessed using a MANOVA for each type of drug information. Any significant variables were analyzed further using univariate analysis. One hundred fifty responses were analyzed. Age and knowledge exerted significant effects on preferences for all three types of information. Context of exposure was not significant in any MANOVA. Overall, respondents reported the strongest preferences for seeking information about a drug seen in a DTC ad from physicians and pharmacists. As DTC advertising becomes more common, continued research on consumer reactions and responses is needed.
引用
收藏
页码:1081 / 1088
页数:8
相关论文
共 50 条
  • [21] Direct-to-Consumer Information and Advertising for Prescription Drugs
    Gress, S.
    Maas, S.
    Wasem, J.
    GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT, 2008, 13 (01): : 19 - 24
  • [22] Consumer tradeoff of advertising claim versus efficacy information in direct-to-consumer prescription drug ads
    Aikin, Kathryn J.
    Betts, Kevin R.
    Ziemer, Kathryn Schaefer
    Keisler, Aysha
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2019, 15 (12): : 1484 - 1488
  • [23] Consumer Believability of Information in Direct-to-Consumer (DTC) Advertising of Prescription Drugs
    Richard F. Beltramini
    Journal of Business Ethics, 2006, 63 : 333 - 343
  • [24] Consumer believability of information in direct-to-consumer (DTC) advertising of prescription drugs
    Beltramini, RF
    JOURNAL OF BUSINESS ETHICS, 2006, 63 (04) : 333 - 343
  • [25] Direct-to-consumer drug information in Europe
    Ager, Brian
    LANCET, 2007, 369 (9564): : 822 - 822
  • [26] Reforming direct-to-consumer advertising
    Bryan A Liang
    Tim Mackey
    Nature Biotechnology, 2011, 29 : 397 - 400
  • [27] Experimenting with direct-to-consumer advertising
    不详
    LANCET, 2000, 356 (9230): : 607 - 607
  • [28] Caring or Compulsion? The Effects of Consumer Attributions of Risk Information Disclosure in Direct-to-Consumer Prescription Drug Advertising
    Ball, Jennifer Gerard
    JOURNAL OF CONSUMER AFFAIRS, 2018, 52 (03) : 623 - 654
  • [29] Direct-to-Consumer Pharmaceutical Advertising
    DeLeo, Vincent A.
    CUTIS, 2016, 97 (01): : 10 - 11
  • [30] Reforming direct-to-consumer advertising
    Liang, Bryan A.
    Mackey, Tim
    NATURE BIOTECHNOLOGY, 2011, 29 (05) : 397 - 400